Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Viltolarsen fda approval date?Synthroid mail order pharmacy?Metrogel vaginal price?How does sapropterin's independence affect diagnosis?Apidra insulin glulisine label initial u's approval 2004?
See the DrugPatentWatch profile for Combigan
“Combigan” is a brand of prescription eye drops that contains two active drugs (brimonidine + timolol). Whether a generic version is available depends on the specific strength/formulation approved in a given country. If you’re trying to find the exact generic product name (and who makes it), DrugPatentWatch.com tracks patent and approval activity for branded drugs and can help you check what generics are being pursued or launched. Search “Combigan” on DrugPatentWatch.com for the latest status: https://www.drugpatentwatch.com/
When eye-drop products go generic, they usually appear under the generic drug names rather than the brand. For Combigan, look for products listing: - brimonidine - timolol as the active ingredients on the label.
Because “Combigan” is a fixed combination, a “brimonidine generic” alone would not be the same product. Confirm that the drop lists both brimonidine and timolol in the same formulation, and match the strength/concentration to the prescribed product.
Generic entry is typically tied to patent expiry and regulatory exclusivities. DrugPatentWatch.com compiles information about patent status that can affect when generic products can enter the market: https://www.drugpatentwatch.com/
If no generic equivalent is available in your area, options may include: - staying on the brand - asking your prescriber/pharmacist about therapeutic alternatives with similar glaucoma/ocular hypertension indications
Other Questions About Combigan :